EA201171413A1 - Способ получения олмесартана медоксомила - Google Patents
Способ получения олмесартана медоксомилаInfo
- Publication number
- EA201171413A1 EA201171413A1 EA201171413A EA201171413A EA201171413A1 EA 201171413 A1 EA201171413 A1 EA 201171413A1 EA 201171413 A EA201171413 A EA 201171413A EA 201171413 A EA201171413 A EA 201171413A EA 201171413 A1 EA201171413 A1 EA 201171413A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- olmesartan medoxomil
- producing olmesartan
- producing
- olm
- removable
- Prior art date
Links
- 239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 title abstract 2
- UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001199 olmesartan medoxomil Drugs 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Согласно настоящему изобретению предложен улучшенный способ получения олмесартана медоксомила, который не содержит ОЛМ-кислоты и имеет более низкое содержание удаляемой и уксуснокислой примеси.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1037DE2009 | 2009-05-20 | ||
PCT/IB2010/052260 WO2010134052A1 (en) | 2009-05-20 | 2010-05-20 | Process for the preparation of olmesartan medoxomil |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201171413A1 true EA201171413A1 (ru) | 2012-09-28 |
Family
ID=42306735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201171413A EA201171413A1 (ru) | 2009-05-20 | 2010-05-20 | Способ получения олмесартана медоксомила |
Country Status (12)
Country | Link |
---|---|
US (1) | US20120184750A1 (ru) |
EP (1) | EP2432777A1 (ru) |
JP (1) | JP2012527446A (ru) |
KR (1) | KR20120046115A (ru) |
CN (1) | CN102459243A (ru) |
AP (1) | AP2011005999A0 (ru) |
AU (1) | AU2010250827A1 (ru) |
BR (1) | BRPI1010969A2 (ru) |
CA (1) | CA2762846A1 (ru) |
EA (1) | EA201171413A1 (ru) |
MX (1) | MX2011012460A (ru) |
WO (1) | WO2010134052A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ305129B6 (cs) * | 2010-11-24 | 2015-05-13 | Zentiva, K.S. | (5-Methyl-2-oxo-1,3-dioxol-4-ylmethyl)-4-(1-hydroxy-1-methyl-propyl)-2-propyl-1-[2´-(1H-tetrazol-5-yl)bifenyl-4-yl-methyl]imidazol-5-karboxylát jako nečistota olmesartan medoxomilu a způsob jeho přípravy |
KR101418871B1 (ko) * | 2012-08-28 | 2014-07-17 | 한국과학기술연구원 | 올메사탄 메독소밀의 정제방법 |
CN104447208B (zh) * | 2014-11-28 | 2016-08-24 | 山东新华制药股份有限公司 | 从奥美沙坦酯生产废液中回收三苯基甲醇的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
CA2141175C (en) | 1994-01-28 | 2006-12-12 | Yasushi Shida | A process for the production of tetrazolyl compounds |
ATE482950T1 (de) | 2003-08-27 | 2010-10-15 | Zentiva Ks | Verfahren zur entfernung der triphenylmethanschutzgruppe |
ITMI20032338A1 (it) | 2003-11-28 | 2005-05-29 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Composti feniltetrazolici. |
KR100953878B1 (ko) | 2004-09-02 | 2010-04-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 올메살탄 메독소밀의 정제 |
CN1976926A (zh) * | 2004-09-02 | 2007-06-06 | 特瓦制药工业有限公司 | 奥美沙坦酯的制备 |
US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
WO2006050922A1 (en) | 2004-11-11 | 2006-05-18 | Lek Pharmaceuticals D.D. | Process for the synthesis of tetrazoles |
EP1716138A1 (en) | 2004-12-30 | 2006-11-02 | Teva Pharmaceutical Industries Ltd | Process for preparing olmesartan medoxomil at ph higher than 2.5 |
CN101094850A (zh) * | 2005-01-03 | 2007-12-26 | 特瓦制药工业有限公司 | 具有较低水平杂质的奥美沙坦酯 |
CZ299902B6 (cs) | 2005-10-27 | 2008-12-29 | Zentiva, A. S | Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv |
US8048904B2 (en) * | 2006-06-19 | 2011-11-01 | Matrix Laboratories Ltd. | Process for the preparation of olmesartan medoxomil |
WO2008043996A2 (en) | 2006-10-09 | 2008-04-17 | Cipla Limited | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
-
2010
- 2010-05-20 MX MX2011012460A patent/MX2011012460A/es not_active Application Discontinuation
- 2010-05-20 CA CA2762846A patent/CA2762846A1/en not_active Abandoned
- 2010-05-20 EP EP10722780.3A patent/EP2432777A1/en not_active Withdrawn
- 2010-05-20 BR BRPI1010969A patent/BRPI1010969A2/pt unknown
- 2010-05-20 JP JP2012511401A patent/JP2012527446A/ja active Pending
- 2010-05-20 EA EA201171413A patent/EA201171413A1/ru unknown
- 2010-05-20 AU AU2010250827A patent/AU2010250827A1/en not_active Abandoned
- 2010-05-20 KR KR1020117030196A patent/KR20120046115A/ko not_active Application Discontinuation
- 2010-05-20 CN CN2010800314916A patent/CN102459243A/zh active Pending
- 2010-05-20 US US13/321,231 patent/US20120184750A1/en not_active Abandoned
- 2010-05-20 WO PCT/IB2010/052260 patent/WO2010134052A1/en active Application Filing
- 2010-05-20 AP AP2011005999A patent/AP2011005999A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20120184750A1 (en) | 2012-07-19 |
WO2010134052A1 (en) | 2010-11-25 |
KR20120046115A (ko) | 2012-05-09 |
EP2432777A1 (en) | 2012-03-28 |
CN102459243A (zh) | 2012-05-16 |
BRPI1010969A2 (pt) | 2019-01-15 |
MX2011012460A (es) | 2012-04-20 |
AP2011005999A0 (en) | 2011-12-31 |
AU2010250827A1 (en) | 2012-01-19 |
CA2762846A1 (en) | 2010-11-25 |
JP2012527446A (ja) | 2012-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201300074A1 (ru) | Способ получения представляющего интерес соединения | |
MX2012005358A (es) | Procedimiento para la preparacion de etexilato de dabigatran. | |
CL2009000503A1 (es) | Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida. | |
WO2011036564A3 (en) | Hyperblebbing shigella strains | |
EA201071058A1 (ru) | Получение леналидомида | |
UA105785C2 (ru) | Способ очистки липопептидов | |
IN2012DN02642A (ru) | ||
CR20120235A (es) | Proceso para la preparación de calcobutrol | |
UA111827C2 (uk) | Спосіб отримання інгенол-3-ангелату | |
WO2011019986A3 (en) | Processes for preparing pemetrexed | |
WO2013121436A3 (en) | A process for preparation of rivaroxaban and intermediates thereof | |
MX2013013891A (es) | Sistema y metodo de tratamiento de agua anti-incrustaciones. | |
WO2012015999A3 (en) | Process for the preparation of imatinib mesylate | |
CL2012000560A1 (es) | Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08). | |
UA106619C2 (ru) | Способ получения производных 1- (2-галогенбифенил-4-ил) -циклопропанкарбоновои кислоты | |
MY158910A (en) | Surface modified silicic acid semi-gels | |
WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
UA106988C2 (ru) | Способ получения 1-бензил-3-гидроксиметил-1h-индазола и его производных и необходимые промежуточные соединения магния | |
WO2013076743A3 (en) | Process for the purification of polyaminocarboxylates | |
MX2010009931A (es) | Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles. | |
EA201270390A1 (ru) | 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения | |
EA201171413A1 (ru) | Способ получения олмесартана медоксомила | |
ATE518828T1 (de) | Ein-topf-verfahren zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat | |
MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. | |
WO2010018441A3 (en) | Process for the preparation of substantially pure telmisartan |